Malignant neoplasms of the eye, orbit, and adnexa (excluding skin)
Malignant neoplasms of the eye, orbit, and adnexa (excluding skin) is rated under 38 CFR 38 CFR § 4.79, Diagnostic Code 6014, from 100% to 100% based on the frequency and functional severity of symptoms. The maximum 100% rating requires: Malignant neoplasms of the eye, orbit, and adnexa (excluding skin) that require therapy that is comparable to those used for systemic malignancies, i.e., systemic chemotherapy, X-ray therapy more extensive than to the area of the eye, or surgery more extensive than enucleation. Most claims establish the 100% or 100% rating before reaching the top tier.
Rating schedule — DC 6014 at a glance
- Minimum rating
- 100%
- Maximum rating
- 100%
- Rating tiers
- 1
- CFR section
- 38 CFR § 4.79
- Body system
- Organs of Special Sense
- Secondary conditions
- 0
Lowest schedular rating available
Full schedular disability
100%
Part 4 rating schedule
None mapped
What are the VA rating criteria for Malignant neoplasms of the eye, orbit, and adnexa (excluding skin)?
Malignant neoplasms of the eye, orbit, and adnexa (excluding skin) that require therapy that is comparable to those used for systemic malignancies, i.e., systemic chemotherapy, X-ray therapy more extensive than to the area of the eye, or surgery more extensive than enucleation
“Malignant neoplasms of the eye, orbit, and adnexa (excluding skin) that require therapy that is comparable to those used for systemic malignancies, i.e., systemic chemotherapy, X-ray therapy more extensive than to the area of the eye, or surgery more extensive than enucleation”
Common Questions About Malignant neoplasms of the eye, orbit, and adnexa (excluding skin) VA Ratings
What is the VA rating range for Malignant neoplasms of the eye, orbit, and adnexa (excluding skin)?
The VA rates Malignant neoplasms of the eye, orbit, and adnexa (excluding skin) under Diagnostic Code 6014 at 100%. The minimum 100% rating requires: Malignant neoplasms of the eye, orbit, and adnexa (excluding skin) that require therapy that is comparable to those used for systemic malignancies, i.e., systemic chemotherapy, X-ray therapy more extensive than to the area of the eye, or surgery more extensive than enucleation. The maximum 100% rating requires: Malignant neoplasms of the eye, orbit, and adnexa (excluding skin) that require therapy that is comparable to those used for systemic malignancies, i.e., systemic chemotherapy, X-ray therapy more extensive than to the area of the eye, or surgery more extensive than enucleation.
Which 38 CFR diagnostic code does the VA use for Malignant neoplasms of the eye, orbit, and adnexa (excluding skin)?
The VA rates Malignant neoplasms of the eye, orbit, and adnexa (excluding skin) under Diagnostic Code (DC) 6014, governed by 38 CFR 38 CFR § 4.79. The diagnostic code establishes the specific rating tiers and severity criteria the VA examiner applies.
Can Malignant neoplasms of the eye, orbit, and adnexa (excluding skin) qualify for TDIU (Total Disability Individual Unemployability)?
Veterans rated for Malignant neoplasms of the eye, orbit, and adnexa (excluding skin) may qualify for TDIU if the condition — alone or in combination with other service-connected disabilities — prevents substantially gainful employment. A single disability rated at 60% or higher (or multiple disabilities combining to 70%, with one at 40%) can support a TDIU claim under 38 CFR § 4.16.
What evidence do I need to establish service connection for Malignant neoplasms of the eye, orbit, and adnexa (excluding skin)?
Service connection for Malignant neoplasms of the eye, orbit, and adnexa (excluding skin) requires three elements: (1) a current diagnosis of the condition, (2) an in-service event, injury, or disease, and (3) a medical nexus linking the current diagnosis to that in-service occurrence. A nexus letter from a treating or independent medical examiner is the most reliable nexus evidence.
What is the C&P exam like for Malignant neoplasms of the eye, orbit, and adnexa (excluding skin)?
A Compensation & Pension (C&P) exam for Malignant neoplasms of the eye, orbit, and adnexa (excluding skin) uses a Disability Benefits Questionnaire (DBQ) specific to the body system involved. The examiner documents the frequency, severity, and functional impact of your symptoms. Bring all relevant treatment records and be prepared to describe your worst-day symptoms — the examiner rates your condition based on the full clinical picture, not a single visit.
Get a Personalized Rating Analysis
VeteranHQ evaluates your symptoms against the exact 38 CFR criteria, identifies secondary conditions, and shows what evidence you need to support a higher rating.
Discover Your Benefits